To examine the associations between diastolic dysfunction indices and longterm risk of all-cause mortality in adults over 23-year follow-up.
| INTRODUC TI ON
Heart failure (HF) is associated with reduced quality of life and premature mortality. 1 It is defined as a clinical syndrome associated with a wide range of left ventricular (LV) structural and functional abnormalities of different underlying etiologies. 2 Recent data suggest that the incidence of HF with reduced LV ejection fraction (HFrEF) and HF with mid-range LV ejection fraction (HFmrEF) is decreasing while incidence of HF with preserved LV ejection fraction (HFpEF)
is increasing.
1
Detection of asymptomatic diastolic dysfunction is a strong risk factor for developing HFpEF. 3 Left atrial (LA) diameter measured in M-mode and mitral flow measurements such as the ratio of the maximal E wave to the maximal A wave (E/A ratio) and the deceleration time of the E wave (DT) has been commonly used as indices of diastolic dysfunction. Enlarged LA diameter is a significant predictor of adverse cardiovascular events. 4 Additionally, LA enlargement has been found to be an independent predictor of HF development, atrial fibrillation, coronary heart disease, stroke, and all-cause mortality.
5-8
A short as well as long DT is associated with poor cardiovascular outcomes. 9 E/A ratio is used for evaluating filling pressure and degree of diastolic dysfunction and also provides prognostic information.
10
The number of studies on the diagnostic impact of LA size and function through the last decades indicates its importance for cardiovascular health. 11 However, there is a lack of data on associations between lower ranges of LA size and all-cause mortality rates.
The American Society of Echocardiography (ASE) and European
Association of Cardiovascular Imaging (EACVI) has put forward a series of LA diameter cutoffs that are defined purely in terms of percentiles of the distribution. Their ability to predict mortality has not so far been ascertained.
12
The recent ASE and EACVI guidelines define diastolic dysfunction in terms of a combination of statistically "normal" values of mitral flow indices derived from a small sample of healthy individuals and predictions of mortality by LA diameter from a surveys of the general population. 13 These guidelines have not validated the combination of these indices as predictors of disease development or mortality. 10, 13 In the latest guidelines septal and lateral e′ peaks, average E/e′ ratio, LA volume index, and peak tricuspid regurgitation velocity are recommended for use as indices for identification of diastolic dysfunction. 10 However, no current population-based cohort has yet the power to examine the predictive value of these newest indices, but several including the Tromsø Study have the possibility to validate the older guidelines, but so far this has not been done. Redfield guidelines have been validated against mortality and morbidity. 16 Our aim was to study the long-term risk of all-cause mortality according to diastolic dysfunction measured as LA diameter and the mitral flow Doppler markers such as DT and E/A ratio using a population-based cohort. In addition, we tested the hypothesis that outcome-derived cutoff values of diastolic dysfunction indices are more accurate for predicting fatal outcomes than normal cutoff values derived from a general population.
| ME THODS

| Study population
The Tromsø Study was initiated in 1974 as a prospective cohort study with the primary aim of assessing the role of modifiable risk factors for cardiovascular diseases. The study design has been described in detail previously. 17 For the purposes of this analysis, we excluded those aged 50 years or younger (n = 470), those with atrial fibrillation (n = 39) during echocardiographic examination to prevent potential inaccuracy of DT measurements, and those who had LVEF <50% (n = 37) in the Tromsø 4 survey. Following these exclusions, 2734 participants were included in the analyses, each having had echocardiography at Tromsø 4 and possibly at later sweeps. The numbers included in analyses of specific endpoints were slightly smaller due to missing data on these parameters: 2616 participants for LA diameter analysis, 2691 participants for DT analysis, and 2699 participants for E/A ratio analysis. We included 1875 participants from the Tromsø 6 survey in additional analysis of the ratio of mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (e′) (E/e′ ratio). Non fasting serum levels of total cholesterol and glycated hemoglobin (HbA1c) were measured according to the previously described procedure.
| Data collection
17,18
| Echocardiography imaging
The echocardiography in the Tromsø 4 survey was performed by two expert cardiologists using a Vingmed CFM 750 ultrasound scanner (Vingmed Sound A/S, Horten, Norway), and details have been described previously. 7 In the Tromsø 5 and 6 surveys, Acuson Seqoia C258 or C512 scanner (Acuson, Mountain view, CA) was used.
19
Coefficients of variation for intra-and inter-observer variability in the Tromsø 4-6 surveys were less than 10% for chamber dimensions and Doppler-derived values. 19, 20 Echocardiographic assessment was performed with the use of standard imaging planes in the left lateral decubitus position according to ASE and EACVI recommendations. 12 All of the echocardiographic measurements were performed online once per examination, but remeasured online if deviating from eye-balled estimates. Mmode echocardiography was used for LA diameter measurement.
LA was measured from the posterior aortic wall to the posterior LA wall using both the parasternal long-axis and short-axis view perpendicular to the aortic root long axis at the level of the aortic sinuses by using the leading edge-to-leading edge convention. 
21
Doppler examination was performed using the apical 4-chamber view with placing of the 2-mm Doppler sample volume between the mitral leaflet tips. For Doppler measurements, the insonation angle was kept as perpendicular as possible toward the mitral inflow to obtain maximal velocity flow in early diastole. Spectral gain was adjusted until the flow curve became clear relatively to the background. 22 Normal values of DT were considered as 140-220 ms. E/A ratio between 0.8 and 1.5 characterize a normal filling pattern.
10
Values of E/e′ ratio used in analysis were within 4-25. Information on the participants who had emigrated from Tromsø was obtained through the Population Register of Norway.
| Follow-up and outcome data
| Statistical methods
Means with standard deviations and proportions were used to describe baseline characteristics of the study participants according to the three categories of LA diameter (<1.5 cm/m 2 ; 1.5-2.3 cm/ m 2 ; >2.3 cm/m 2 ), DT (<140 ms; 140-220 ms; >220 ms), and E/A ratio (<0.8; 0.8-1.5; >1.5). Means (except for age) and proportions were adjusted for age using linear or logistic regression, respectively.
Associations of the three echocardiographic variables with all-cause mortality were assessed using time-dependent Cox proportional hazards regression models with fractional polynomials of LA diameter, DT, and E/A ratio as the main predictors. Baseline information for the participants can change during a follow-up period of 23 years. To take into account these changes, we updated baseline information for those participants who also attended following surveys using time-dependent Cox regression. Models were tested for possible interactions between sex and LA diameter, DT, E/A ratio, and E/e′ ratio. We found no interaction between sex and LA diameter, sex and DT, sex and E/A ratio, or sex and E/e′ ratio (P = 0.489, P = 0.696, P = 0.199, and 0.730, respectively), and therefore, results were presented for men and women combined.
We chose the best-fitting fractional polynomials of LA diameter,
DT, E/A ratio, and E/e′ ratio while adjusting for sex and fractional polynomials of age using the Akaike information criterion. BMI = body mass index; DBP = diastolic blood pressure; DT = mitral peak E deceleration time; E/A = mitral peak E to peak A ratio; HbA1c = glycated hemoglobin; SBP = systolic blood pressure. Values in the table are mean (standard deviation) or number (%). Means (except for age) and proportions were adjusted for age using linear or logistic regression, respectively.
TA B L E 2 Baseline characteristics of study participants by left atrial diameter (n = 2616); the Tromsø Study 1994-1995 or E/e′ ratio was used to test the associations. The proportional hazard assumption was met in all models.
The best cutoff values for LA diameter, DT, and E/A ratio were estimated using receiver operating characteristic (ROC) curves and AUCs.
We used the maximum value of Youden's index as a criterion for selecting the optimal cutoff points for LA diameter, DT, and E/A ratio.
24
For the two latter with an U-shaped relation to risk, ROC curves were estimated for the upper and lower part of values separately.
A two-sided P < 0.05 was considered statistically significant. All statistical analyses were performed using SAS statistical package, version 9.4 (SAS Institute, Cary, NC).
| Ethical considerations
The study conformed to the principles outlined in the Declaration 
| RE SULTS
| Baseline characteristics
The baseline clinical and echocardiographic characteristics of the study participants are presented according to the three ASE and EACVI categories of LA diameter (Table 2) , DT (Table 3) , and E/A ratio (Table 4) .
| LA diameter, DT, E/A and E/e′ ratios, and allcause mortality
We found that models with LA diameter, DT, and E/A ratio adjusted for age and sex showed the very similar pattern of HRs compared to the fully adjusted models. We identified a U-shaped association between LA diameter and all-cause death ( Figure 2 BMI = body mass index; DBP = diastolic blood pressure; E/A = mitral peak E to peak A ratio; HbA1c = glycated hemoglobin; LA = left atrium; SBP = systolic blood pressure. Values in the table are mean (standard deviation) or number (%). Means (except for age) and proportions were adjusted for age using linear or logistic regression, respectively.
TA Left atrial diameter of 1.8 cm/m 2 corresponded to the lowest HR in both age-and sex-adjusted and fully adjusted models (Figure 2 ), and accordingly, we estimated the optimal cutoff points based on ROC curve analysis above and below this value. The AUC for LA diameter values ≤1.8 cm/m 2 was 0.56 (P = 0.117). The optimal lower cutoff value for LA diameter was estimated as 1.7 cm/m 2 . For those with LA diameter >1.8 cm/m 2 , the AUC value was 0.60 (P < 0.001) with an optimal upper cutoff point for LA diameter of 2.3 cm/m 2 ( Table 5) .
Association between mitral peak E DT and risk of all-cause death was U-shaped ( Figure 3 ). In the sex-and age-adjusted model, The DT value of 155 ms conferred the lowest risk, and the population was accordingly divided at this value. For those with DT levels ≤155 ms (AUC = 0.56, P = 0.030), an optimal cutoff point was 150 ms. AUC for those with DT >155 ms was 0.60, P < 0.001. Here a value of 200 ms was the best cutoff point with 67% sensitivity and 50% specificity (Table 5 ).
Similarly to LA and DT, the association between mitral valve E/A ratio and risk of death was U-shaped. Sex-and age-adjusted HRs of death for E/A ratio of 0. BMI = body mass index; DBP = diastolic blood pressure; DT = mitral peak E deceleration time; E/A = mitral peak E to peak A ratio; HbA1c = glycated hemoglobin; LA = left atrium; SBP = systolic blood pressure. Values in the table are mean (standard deviation) or number (%). Means (except for age) and proportions were adjusted for age using linear or logistic regression, respectively.
TA B L E 4 Baseline characteristics of study participants by mitral peak E to peak A ratio (n = 2699); the Tromsø Study 1994-1995 divided into two groups. Lower part of values with E/A ratio ≤1.1 had an AUC of 0.54, P < 0.001. An optimal cutoff was considered as 0.6. Results of ROC curve analysis for those with E/A ratio >1.1
showed that AUC was 0.58, P < 0.001. The best cutoff value for E/A ratio >1.1 equals 1.2 with levels of sensitivity of 67% and specificity of 46% (Table 5) .
Optimal cutoff values for all-cause mortality derived from timedependent Cox regression models adjusted for age and sex were left ventricular filling indices did not result in increase of AUC. HRderived cutoffs produced identical AUCs and were not presented.
Receiver operating characteristic analysis using ASE and EACVI recommended cutoffs revealed the highest AUCs when LA diameter was combined with DT and with DT+E/A ratio. These combinations gave AUCs of 0.63.
We revealed a cubic association between E/e′ ratio and all-cause mortality ( Figure 5 ). In the age-and sex-adjusted model, those with F I G U R E 3 Mitral peak E deceleration time (DT) and all-cause mortality. The Tromsø Study. P-value: Likelihood ratio test between a model with and a model without fractional polynomial terms of DT. *Adjusted for sex and fractional polynomials of age. **Adjusted for sex, fractional polynomials of age, mean systolic blood pressure, body mass index, total cholesterol, stroke, angina, myocardial infarction, smoking, and antihypertensive treatment. HR = hazard ratio; LCI = lower 95% confidence interval; UCI = upper 95% confidence interval F I G U R E 4 Mitral peak E to peak A ratio and all-cause mortality. The Tromsø Study. P-value: Likelihood ratio test between a model with and a model without fractional polynomial terms of E/A ratio. *Adjusted for sex and fractional polynomials of age. **Adjusted for sex, fractional polynomials of age, mean systolic blood pressure, body mass index, total cholesterol, stroke, angina, myocardial infarction, smoking, and antihypertensive treatment. HR = hazard ratio; LCI = lower 95% confidence interval; UCI = upper 95% confidence interval 
| D ISCUSS I ON
| Results overview
Our study reveals that echocardiographic markers of diastolic dysfunction such as LA diameter, DT, and E/A ratio can be used for prediction of all-cause mortality risk. We were able to estimate HRs for all of the described parameters, assess new outcome-derived cutoff points for them, and describe the best combinations of echocardiographic markers for all-cause mortality outcome prediction.
The association remained U-shaped after additional adjustment for systolic blood pressure, body mass index, total cholesterol, smoking, antihypertensive treatment, history of stroke, angina, and myocardial infarction. It shows that LA diameter, DT, and E/A ratio each has independent effects on all-cause mortality also after adjustment for sex, age, and cardiovascular risk factors. We also used all-cause mortality risk estimation models for assessing optimal cutoffs of the left ventricular filling indices. These cutoffs were slightly different from those obtained with maximal Youden index but gave identical prediction ability for all-cause mortality outcome.
| Comparison with other studies
| Left atrial diameter
Left atrial diameter has been shown to be an important prognostic parameter of mortality in several but not all studies conducted in general population samples.
5, 25 Pritchett et al 26 reported that BSA-indexed LA volume was not associated with all-cause mortality when adjusted for age, gender, ejection fraction, and diastolic dysfunction grade. Diversity in results may be explained by differences in the study populations, methods of LA diameter measurement, and indexation.
In our study, the HRs for LA diameter above the reference of 
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The underlying mechanisms linking an enlarged LA diameter with increased all-cause mortality have been described previously. 27 Elevated LA filling pressures, decreased flow velocities in LA appendages, atrial fibrillation as well as structural heart disease and hypertension are among those mechanisms which result in all-cause mortality risk increase.
A novel finding of our study is that LA diameter below 1.5 cm/ m 2 independently increases risk of all-cause death. This finding is supported by a few recent studies, however with several limitations.
Aviram et al 28 found that decreased LA volume was associated with increased mortality risk in patients with acute pulmonary embolism.
Rozenbaum et al 29 also reported that patients with very small LA F I G U R E 5 Mitral peak E to peak e′ ratio and all-cause mortality. The Tromsø Study. P-value: Likelihood ratio test between a model with and a model without fractional polynomial terms of E/e′ ratio. *Adjusted for sex and fractional polynomials of age. **Adjusted for sex, fractional polynomials of age, mean systolic blood pressure, body mass index, total cholesterol, stroke, angina, myocardial infarction, smoking, and antihypertensive treatment. HR = hazard ratio; LCI = lower 95% confidence interval; UCI = upper 95% confidence interval volume index <24 mL/m 2 had HR of 3.6 (95% CI: 1.46-8.87) for allcause mortality. Limitations of these studies were small sample sizes and short follow-up periods. Acquisition of images in these studies was based on computed tomography. To our knowledge, there are no literature data on the association of small atrial diameters and allcause mortality rates based on two-dimensional echocardiography.
One of the possible explanations of association between small LA size and mortality could be a decrease of LA emptying fraction, a functional parameter, which is independently associated with LA remodeling and mortality prediction. We defined lower and upper cutoffs with optimal sensitivity and specificity levels using the Youden index. Thus, lower reference cutoff value for LA diameter was 1.7 cm/m 2 (ROC curve P-value = 0.117) which is higher than the ASE and EACVI recommended value of 1.5 cm/m 2 . According to our findings, the value of 1.5 cm/m 2 has a higher sensitivity level of 81% which corresponds to the higher negative predictive value. The upper cutoff point was 2.3 cm/m 2 with a 46% sensitivity and 71% specificity and had significantly higher risk than 2.1 cm/m 2 , which conforms to recent recommendations. 
| Mitral peak E deceleration time
In our study, the optimal cutoff level for lower DT reference value was defined as 150 ms which is higher than the current normalitybased cutoff of 140 ms. 10 It was a key parameter in Redfield definition 14 and has shown strong independent predictive ability in patient population with myocardial infarction. Unlike the U-shaped relationships between all-cause mortality and LA size or E/A ratio with a narrow normal range, DT effect is linked to extreme values at each end of a wide normal range in concordance with ASE and EACVI normality cutoffs. However, our approach of using outcome-derived values allowed narrowing the fraction of DT middle values and improves risk assessment non significantly.
| E/A ratio
Results from the second wave in the Strong Heart Study indicated that in middle-aged and elderly participants, an E/A ratio level above 1.5 was independently associated with a twofold increase in allcause mortality risk. 33 E/A levels below 0.6 were similarly associated with increased mortality risk. In our study, the risk of all-cause mortality increased gradually for E/A values above 1.3. Risk of allcause mortality increased also with decreasing E/A ratios starting from 0.8.
Analysis of the predictive ability of E/A ratio showed that optimal cutoffs differed from those recommended by ASE and EACVI. Thus, the lower optimal cutoff was found as 0.6 with a corresponding 17% sensitivity and 89% specificity. Upper cutoff value of 1.2 had a specificity level of 46% which is lower than ASE and EACVI guidelinebased E/A ratio value of 1.5 (specificity 59%) with all-cause mortality as outcome.
| E/e′ ratio
Our findings suggest that an elevated E/e′ ratio is independently associated with increased risk of all-cause mortality in a general population. This is in contrast to Mogelvang et al 34 in the Copenhagen City Heart Study who found no association of E/e′ with overall mortality. Kuznetsova et al 16 reported borderline association of E/e′ ratio and risk of cardiac events. These studies had 90 and 59 cases respectively and half the follow-up time of our study where 240 cases and 10 years follow-up increases power in support of our finding. Interestingly, E/e′ did not have a superior predictive ability for overall mortality when compared with other diastolic dysfunction markers.
| Comparison of prognostic values of LA diameter, DT, and E/A
We aimed to explore the hypothesis that reference values based on outcome data would predict all-cause mortality better than those recommended by ASE and EACVI. The outcome-derived model, which combines LA diameter, DT, and E/A ratio, showed the best prediction on all-cause mortality, but not significantly different from the model with only LA diameter and DT included.
Using the cutoff values from current ASE and EACVI classification of diastolic dysfunction gave the same AUCs for LA diameter as Youden index-based outcome-derived cutoffs. For models with the three variables combined, the largest AUC was detected in LA diameter+DT+E/A ratio model (AUC = 0.63, P < 0.001) which was the same as in a model with ASE and EACVI cutoff values. When assessing the incremental value of each parameter, both DT and E/A ratio added prognostic value to LA diameter, but E/A ratio did not add to the prognostic accuracy of LA diameter in combination with DT.
| Study strengths and limitations
This was a large prospective population-based study with a long follow-up period. The prospective design of the Tromsø study and a random sample of a large age span from the general population with a high attendance rate increases generalizability to other Caucasian populations. Another strength was the updating of baseline values as the participants attended following surveys. Although biplane or 3D echocardiography is now regarded as the most accurate methods of LA volume estimation, M-mode anteroposterior LA diameter has higher intra-and inter-observer reproducibility especially while assessing minimal atrial dimensions.
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A main limitation of the study is that we used M-mode-based linear measurements of LA which is less accurate than those based 
| CON CLUS IONS
Our study concludes that not only enlarged but also small LA diameter is associated with increased all-cause mortality risk. Using our new outcome-derived cutoffs of LA diameter, DT, and E/A ratio did not result in a better predictive ability for all-cause mortality in comparison with current ASE and EACVI recommended cutoff points. A combination of the Doppler-based LV filling parameter DT with LA diameter is preferable while assessing risk of all-cause mortality, while E/A ratio did not add incremental value.
